Brief: Transgene And BioInvent To Present Data On BT-001

Transgene SA

03/03/2020 07:44

March 3 (Reuters) - TRANSGENE SA  TRNG.PA :
    * TRANSGENE AND BIOINVENT TO PRESENT DATA ON BT-001, AN
ONCOLYTIC
VIRUS ENCODING FOR AN ANTI-CTLA4 ANTIBODY, AT UPCOMING
CONGRESSES
    * COMPREHENSIVE DATA PACKAGE SUPPORTS PENDING CLINICAL TRIAL
APPLICATION FOR FIRST-IN-HUMAN STUDY OF BT-001
    * ONCOLYTIC VIRUS DESIGN AND PRECLINICAL DATA TO BE
PRESENTED AT
ESMO TAT, IO SUMMIT EUROPE, KEYSTONE SYMPOSIUM AND AACR 2020
    * WE ARE VERY MUCH LOOKING FORWARD TO INVESTIGATE BT-001 IN
ITS
FIRST-IN-HUMAN STUDY, WHICH IS PLANNED TO START BEFORE END OF
2020.
    * FIRST-IN-HUMAN TRIAL IS EXPECTED TO START BEFORE END OF
2020 IN
EUROPE AND USA.

Source text for Eikon:  ID:nBw8VLvs2a 
Further company coverage:  TRNG.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))